http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112138044-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4884983cf128a793a8b27a24f50e093b
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-331
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-51
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-37
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-513
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-708
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-287
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-355
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-315
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-41
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-79
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-539
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-195
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-634
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-708
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-41
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-513
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-79
filingDate 2020-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bb46b7ba905483a8c55458c19ac46c56
publicationDate 2020-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-112138044-A
titleOfInvention A kind of composition for treating hepatitis B and preparation method thereof
abstract The invention provides a composition for treating hepatitis B and a preparation method thereof. The composition comprises ebselen, organic germanium Ge-132, lamivudine, schisandra, isatidis, forsythia, rhubarb, wild chrysanthemum, Shuanghuanglian, wherein the parts by weight ratio of ebselen, organic germanium Ge-132, lamivudine, Schisandra chinensis, Radix isatidis, forsythia, rhubarb, wild chrysanthemum, and Shuanghuanglian are 1:4-8:2: 0.5: 0.5: 0.5: 0.5: 0.5: 0.5, the preparation device used to prepare the above composition includes a reaction kettle, a mixer, a concentrator, a vacuum dryer and a tablet press. On the basis of the treatment of ), the use of ebselen organic germanium (Ge‑132), Schisandra chinensis, isatis root, forsythia, rhubarb, wild chrysanthemum, and Shuanghuanglian have obvious effects against hepatitis B virus. There are major breakthroughs in the curative effect, the overall curative effect is fast and good, and the rebound ratio is smaller.
priorityDate 2020-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60825
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID408426700
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6326954
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419582621
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419523132
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3194

Total number of triples: 41.